Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improving Family Communication.
Medrano V, Bonilla G, Hernández E, Romanjek MH, Gómez A, Hernández J, Reyes MR, Lindenberg CS. Medrano V, et al. Hisp Health Care Int. 2017 Mar;15(1):35-42. doi: 10.1177/1540415317696201. Hisp Health Care Int. 2017. PMID: 28558510
Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders.
Guasp M, Rosa-Justicia M, Muñoz-Lopetegi A, Martínez-Hernández E, Armangué T, Sugranyes G, Stein H, Borràs R, Prades L, Ariño H, Planagumà J, De-La-Serna E, Escudero D, Llufriu S, Sánchez-Valle R, Santamaria J, Compte A, Castro-Fornieles J, Dalmau J; Spanish anti-NMDAR Encephalitis Study Group. Guasp M, et al. Lancet Neurol. 2022 Oct;21(10):899-910. doi: 10.1016/S1474-4422(22)00299-X. Lancet Neurol. 2022. PMID: 36115362
Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance.
Sacco S, Lampl C, Maassen van den Brink A, Caponnetto V, Braschinsky M, Ducros A, Little P, Pozo-Rosich P, Reuter U, Ruiz de la Torre E, Sanchez Del Rio M, Sinclair AJ, Martelletti P, Katsarava Z; Burden and Attitude to Resistant and Refractory (BARR) Study Group. Sacco S, et al. J Headache Pain. 2021 May 18;22(1):39. doi: 10.1186/s10194-021-01252-4. J Headache Pain. 2021. PMID: 34006218 Free PMC article.
OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study.
Domínguez C, Pozo-Rosich P, Torres-Ferrús M, Hernández-Beltrán N, Jurado-Cobo C, González-Oria C, Santos S, Monzón MJ, Latorre G, Álvaro LC, Gago A, Gallego M, Medrano V, Huerta M, García-Alhama J, Belvís R, Leira Y, Leira R. Domínguez C, et al. Among authors: medrano v. Eur J Neurol. 2018 Feb;25(2):411-416. doi: 10.1111/ene.13523. Epub 2017 Dec 18. Eur J Neurol. 2018. PMID: 29171146
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim YS, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr MB; MODIFY I and MODIFY II Investigators. Wilcox MH, et al. N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615. N Engl J Med. 2017. PMID: 28121498 Free article. Clinical Trial.
LAM study: Effects of lacosamide on behaviour and quality of life in patients with epilepsy.
Alfaro A, Asensio M, García-Escrivá A, Medrano V, Salom JM, Tortosa D, Palao S, Lezcano M, Berenguer L, Navarro M, Cerdán M, Buendía JF, Giner JC. Alfaro A, et al. Among authors: medrano v. Neurologia (Engl Ed). 2019 Jan-Feb;34(1):1-6. doi: 10.1016/j.nrl.2016.10.007. Epub 2016 Dec 16. Neurologia (Engl Ed). 2019. PMID: 27993420 Free article. English, Spanish.
[Effect of lacosamide on the quality of life of patients with epilepsy].
García-Escrivá A, López-Hernández N, Llorca V, Alfaro A, Asensio-Asensio M, García C, Lezcano-Rodas M, Medrano V, Palao S. García-Escrivá A, et al. Among authors: medrano v. Rev Neurol. 2014 Aug 16;59(4):145-52. Rev Neurol. 2014. PMID: 25059264 Free article. Spanish.
50 results